A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
Pain Management in Aneurysmatic Subarachnoid Haemorrhage: A Survey of Nordic Physicians
Tekijät: Sariola, Hanna; Kalliomäki, Maija‐Liisa; Kiiski, Heikki; Raatikainen, Essi; Frösen, Juhana; Reinikainen, Matti; Savioja, Hanna; Møller, Kirsten; Lohela, Terhi; Takala, Riikka; Sigurdsson, Martin; Romundstad, Luis; Dyrskog, Stig; Bülow, Karsten; Hästbacka, Johanna
Kustantaja: Wiley
Julkaisuvuosi: 2026
Lehti: Acta Anaesthesiologica Scandinavica
Artikkelin numero: e70194
Vuosikerta: 70
Numero: 3
ISSN: 0001-5172
eISSN: 1399-6576
DOI: https://doi.org/10.1111/aas.70194
Julkaisun avoimuus kirjaamishetkellä: Avoimesti saatavilla
Julkaisukanavan avoimuus : Osittain avoin julkaisukanava
Verkko-osoite: https://doi.org/10.1111/aas.70194
Rinnakkaistallenteen osoite: https://research.utu.fi/converis/portal/detail/Publication/508964213
Rinnakkaistallenteen lisenssi: CC BY NC ND
Rinnakkaistallennetun julkaisun versio: Kustantajan versio
Background
Headache caused by aneurysmatic subarachnoid hemorrhage (aSAH) is often severe and may persist long after the ictus. Pharmacological pain management can be challenging due to poor efficacy or adverse effects. Multimodal pharmacotherapy is often required. Lack of guidelines and good quality clinical studies on pain management has led to variation in pain management practices. Knowledge of current practice and goals of pain management in Nordic countries is lacking. We aimed to fill these knowledge gaps by conducting a survey targeting Nordic clinicians involved in aSAH treatment.
MethodsAn electronic survey in English was sent to national coordinators in December 2023. The coordinators distributed the survey to intensivists, neurosurgeons, and other specialists treating aSAH patients in their respective countries. The survey contained 63 questions gathering background information, current aSAH pain management during the hospital stay and at hospital discharge, follow-up, and preferred outcome measures regarding a clinical trial on pain management in aSAH. The results were analysed and presented descriptively.
ResultsWe received 70 responses: 36 from Finland, 11 from Norway, 11 from Denmark, 5 from Sweden and 7 from Iceland. Respondents were intensivists (N = 46), neurosurgeons (N = 20), neurologists (N = 2), and others (N = 2). The most frequently used pain medications at ICUs were paracetamol, opioids, and non-steroidal anti-inflammatory drugs (NSAID). Most neurosurgeons (70%, N = 14) responded that they never prescribe opioids at hospital discharge for aSAH patients. The most preferred outcome for a clinical trial was patients' self-reported quality of life.
ConclusionsIn the Nordic countries, paracetamol, opioids, and NSAIDs were reported as the most frequently used analgesics in the management of aSAH related pain in the ICU. Use of gabapentinoids was commonly reported by Danish respondents, unlike respondents from other Nordic countries. Neurosurgeons reported that they rarely prescribe opioids at hospital discharge.
Editorial CommentThis survey of Nordic clinicians involved in ICU and neurosurgical management of subarachnoid bleed (aneurysm) cases presents preferences for pain management in hospital and with discharge, as well as assessing clinician preferences for outcomes by which to assess pain management in these cases.
Ladattava julkaisu This is an electronic reprint of the original article. |
Julkaisussa olevat rahoitustiedot:
This work was supported by Suomen Anestesiologiyhdistys; State funding for university-level health research, Tampere University Hospital, Wellbeing services county of Pirkanmaa, Project number T63804.